Malignant Salivary Gland Neoplasm — Trials

Malignant Salivary Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 63
Recruiting: 32
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 21.4%
Trials / 1,000 deaths: 56.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05898373	Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC	unknown	Phase 1 / Phase 2	120	Peking Union Medical CollegeOTHER	0	Jun 12, 2023	clinicaltrials
NCT03291002	Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC	unknown	Phase 1	98	CureVacINDUSTRY	5	Nov 4, 2021	clinicaltrials
NCT01192087